Responsible use of rifampin for the treatment of latent tuberculosis infection.
作者信息
Batt Jane, Khan Kamran
机构信息
Keenan Research Centre for Biomedical Science (Batt), St. Michael's Hospital; Division of Respirology, Department of Medicine (Batt), University of Toronto; Li Ka Shing Knowledge Institute (Khan), St. Michael's Hospital; Division of Infectious Diseases, Department of Medicine (Khan), University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2019 Jun 24;191(25):E678-E679. doi: 10.1503/cmaj.190081.
Abstract
摘要
相似文献
1
Responsible use of rifampin for the treatment of latent tuberculosis infection.利福平在潜伏性结核感染治疗中的合理应用。
CMAJ. 2019 Jun 24;191(25):E678-E679. doi: 10.1503/cmaj.190081.
2
Tolerability of rifampin monotherapy for latent tuberculosis infection in children.利福平单药治疗儿童潜伏性结核感染的耐受性
Pediatr Infect Dis J. 2011 Nov;30(11):1014-5. doi: 10.1097/INF.0b013e31823234c9.
3
Practice guideline for treatment of latent tuberculosis infection in children.儿童潜伏性结核感染治疗实践指南。
J Pediatr Health Care. 2015 May-Jun;29(3):302-7. doi: 10.1016/j.pedhc.2015.02.002. Epub 2015 Mar 17.
4
Treatment of latent tuberculosis infection.潜伏结核感染的治疗。
Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20.
5
Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.3 个月利福平与异烟肼化学预防疗法治疗儿童潜伏性结核感染的效果。
Arch Dis Child. 2010 Aug;95(8):600-2. doi: 10.1136/adc.2010.182600. Epub 2010 Jun 7.
6
Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis Infection.潜伏性结核感染治疗后诊断出的活动性肺结核的临床特征。
Clin Infect Dis. 2020 Aug 22;71(5):1320-1323. doi: 10.1093/cid/ciz1157.
7
Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.用于潜伏性结核感染的异烟肼、利福平及吡嗪酰胺两个月疗程
Public Health. 2012 Sep;126(9):760-2. doi: 10.1016/j.puhe.2012.04.008. Epub 2012 May 24.
8
Cost-effectiveness of rifampin for 4 months and isoniazid for 6 months in the treatment of tuberculosis infection.利福平治疗 4 个月与异烟肼治疗 6 个月治疗结核感染的成本效益。
Respir Med. 2013 May;107(5):768-77. doi: 10.1016/j.rmed.2013.01.017. Epub 2013 Mar 13.
9
Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.美国结核病诊所采用利福平 4 个月方案治疗儿童潜伏性结核病的效果更好。
Pediatr Infect Dis J. 2018 Mar;37(3):224-228. doi: 10.1097/INF.0000000000001721.
10
Considering the role of four months of rifampin in the treatment of latent tuberculosis infection.考虑利福平四个月疗程在潜伏性结核感染治疗中的作用。
Am J Respir Crit Care Med. 2004 Oct 15;170(8):832-5. doi: 10.1164/rccm.200405-584PP. Epub 2004 Aug 5.
引用本文的文献
1
Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment.对抗耐多药结核病的创新策略：药物递送系统与治疗的进展
Microorganisms. 2025 Mar 24;13(4):722. doi: 10.3390/microorganisms13040722.
2
Short Combination Treatment for Latent Tuberculosis in Children.儿童潜伏性结核病的短程联合治疗
J Korean Med Sci. 2024 Feb 26;39(7):e97. doi: 10.3346/jkms.2024.39.e97.
3
Latent Tuberculosis Treatment among Hard-to-Reach Ethiopian Immigrants: Nurse-Managed Directly Observed versus Self-Administered Isoniazid Therapy.难以接触到的埃塞俄比亚移民中的潜伏性结核病治疗：护士管理的直接观察与自我给药异烟肼治疗
Trop Med Infect Dis. 2023 Feb 16;8(2):123. doi: 10.3390/tropicalmed8020123.
4
Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.异烟肼或利福平预防治疗联合或不联合筛查潜伏性结核：建模分析。
BMC Med. 2021 Dec 14;19(1):315. doi: 10.1186/s12916-021-02189-w.
5
No evidence of increased risk of acquired rifampin resistance.无获得性利福平耐药风险增加的证据。
CMAJ. 2019 Nov 25;191(47):E1314-E1315. doi: 10.1503/cmaj.73353.
6
Responsible use of rifampin in Canada is threatened by irresponsible shortages.加拿大利福平的合理使用受到不负责任的短缺情况的威胁。
CMAJ. 2019 Oct 15;191(41):E1139. doi: 10.1503/cmaj.73160.
本文引用的文献
1
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.成人潜伏性结核：利福平治疗 4 个月或异烟肼治疗 9 个月。
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
2
Rifampicin resistance after treatment for latent tuberculous infection: a systematic review and meta-analysis.潜伏性结核感染治疗后的利福平耐药性：一项系统评价和荟萃分析。
Int J Tuberc Lung Dis. 2016 Aug;20(8):1065-71. doi: 10.5588/ijtld.15.0908.
3
Towards tuberculosis elimination: an action framework for low-incidence countries.迈向消除结核病：低发病率国家的行动框架。
Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014.
4
Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.2005 - 2007年美国耐多药和广泛耐药结核病的治疗方法、治疗结果及费用
Emerg Infect Dis. 2014 May;20(5):812-21. doi: 10.3201/eid2005.131037.
5
Three months of rifapentine and isoniazid for latent tuberculosis infection.利福喷丁和异烟肼治疗潜伏性结核感染 3 个月。
N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.
6
Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis.诱导痰检查在肺结核诊断中的应用：系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1619-30. doi: 10.1007/s10096-011-1485-6. Epub 2011 Nov 18.
7
High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.HIV-1 感染者中无严重免疫缺陷者的亚临床结核病高发：对结核病筛查的影响。
Thorax. 2011 Aug;66(8):669-73. doi: 10.1136/thx.2011.160168. Epub 2011 May 31.
8
Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.高 HIV 流行环境中异烟肼预防性治疗暴露者的结核病结局和药物敏感性。
AIDS. 2010 Apr 24;24(7):1051-5. doi: 10.1097/QAD.0b013e32833849df.
9
Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands.荷兰移民患者结核病的直接和间接成本。
BMC Public Health. 2009 Aug 5;9:283. doi: 10.1186/1471-2458-9-283.
10
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review.连续痰标本检查在肺结核诊断中的阳性率：一项系统评价
Int J Tuberc Lung Dis. 2007 May;11(5):485-95.
Zotero 插件